Drug Shortage Report for CHOLESTYRAMINE-ODAN
Report ID | 96259 |
Drug Identification Number | 02455609 |
Brand name | CHOLESTYRAMINE-ODAN |
Common or Proper name | Cholestyramine for Oral Suspension, USP |
Company Name | ODAN LABORATORIES LTD |
Market Status | MARKETED |
Active Ingredient(s) | CHOLESTYRAMINE RESIN |
Strength(s) | 4G |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL |
Packaging size | 4g |
ATC code | C10AC |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2019-10-11 |
Estimated end date | 2020-01-10 |
Actual end date | 2020-01-08 |
Shortage status | Resolved |
Updated date | 2020-01-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2020-01-09 | English | Compare |
v10 | 2020-01-08 | French | Compare |
v9 | 2020-01-08 | English | Compare |
v8 | 2019-12-30 | French | Compare |
v7 | 2019-12-30 | English | Compare |
v6 | 2019-12-18 | French | Compare |
v5 | 2019-12-18 | English | Compare |
v4 | 2019-10-12 | English | Compare |
v3 | 2019-10-11 | French | Compare |
v2 | 2019-10-11 | English | Compare |
v1 | 2019-10-11 | English | Compare |
Showing 1 to 11 of 11